Look for Drugs and Conditions

Hydrocortisone-17 Butyrate

Hydrocortisone-17 Butyrate

Hydrocortisone-17 Butyrate is a synthetic corticosteroid used in topical treatments for various skin conditions. It possesses anti-inflammatory, antipruritic, and vasoconstrictive properties, making it effective in managing skin inflammations, such as eczema, psoriasis, and dermatitis.

Indications

Hydrocortisone-17 Butyrate is primarily indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as eczema, psoriasis, dermatitis, and other inflammatory skin conditions.


Dosage

The dosage of hydrocortisone-17 butyrate will vary depending on the condition being treated, the formulation used, and the age of the patient. It is typically applied to the affected area of the skin in a thin layer 1-2 times daily, or as directed by a healthcare professional. The treatment duration and frequency should be carefully monitored to avoid overuse and possible side effects.


Contra-Indications

Hydrocortisone-17 butyrate is contraindicated in individuals who are hypersensitive to hydrocortisone or any of the components of the formulation. It should not be applied to open wounds, infected skin, or areas with broken skin.


Special Precautions

-Prolonged use of hydrocortisone-17 butyrate can lead to thinning of the skin and other adverse effects such as stretch marks and easy bruising. -In pediatric patients, the drug may suppress growth and development, so it should be used with caution. -Avoid using the drug on the face, groin, or axillary areas unless specifically directed by a healthcare professional.


Side Effects

Skin thinning and atrophy Stretch marks Bruising Acne Rosacea-like rash


Drug Interactions

There are typically no significant drug interactions with topical hydrocortisone-17 butyrate. However, concurrent use of other skin medications or treatments should be monitored and reviewed by a healthcare professional.


Other Brands With Same Generic
Brand Name Manufactured by
LOCOID ELDER PHARMACEUTICALS LTD.
Ad 5